secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001628280-26-017222
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q4 net loss narrows to $8.1M; adjusted EBITDA margin 18.3%
-----------------------------------------------------------------------

- Net sales Q4 $82.4M (down 1% YoY); full year $300.8M (down 10% YoY).
- Gross margin improved to 64.4% Q4 and 65.3% FY, up from 62.7% and 54.5%.
- Adjusted EBITDA Q4 $15.0M (18.3% margin) vs $9.0M (10.8%) YoY; FY $45.1M vs $12.3M.
- Delivery systems sold Q4 1,032 (-5% YoY); active install base rose to 36,026 (+3.7%).
- CEO cites operational improvements, strong install base, and recurring consumables model.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026017222/0001628280-26-017222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026017222/skin-20260312.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-017222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer